U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Drug Shortages

FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages | Contact Us

Start Over | Back to Previous Screen

Lisdexamfetamine Dimesylate Capsule
Status: Currently in Shortage
»Date first posted: 07/14/2023
»Therapeutic Categories: Psychiatry

Expand all

Alvogen (Reverified 12/03/2024)

Company Contact Information:
844-842-8672 and email: CustomerService-US@alvogen.com

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Capsule, 10 mg (NDC 47781-562-01) Available Shortage of an active ingredient
Capsule, 20 mg (NDC 47781-563-01) Limited Availability Resupply November 2024 Shortage of an active ingredient
Capsule, 30 mg (NDC 47781-564-01) Available Shortage of an active ingredient
Capsule, 40 mg (NDC 47781-565-01) Limited Availability Resupply November 2024 Shortage of an active ingredient
Capsule, 50 mg (NDC 47781-566-01) Limited Availability Resupply November 2024 Shortage of an active ingredient
Capsule, 60 mg (NDC 47781-567-01) Limited Availability Resupply November 2024 Shortage of an active ingredient
Capsule, 70 mg (NDC 47781-568-01) Limited Availability Resupply November 2024 Shortage of an active ingredient

Amneal Pharmaceuticals (Reverified 11/19/2024)

Company Contact Information:
866-525-7270

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Capsule, 20 mg (NDC 65162-023-09) Unavailable Shortage of an active ingredient Shortage of an active ingredient
Capsule, 30 mg (NDC 65162-024-09) Unavailable Shortage of an active ingredient Shortage of an active ingredient
Capsule, 40 mg (NDC 65162-025-09) Unavailable Shortage of an active ingredient Shortage of an active ingredient
Capsule, 50 mg (NDC 65162-026-09) Unavailable Shortage of an active ingredient Shortage of an active ingredient
Capsule, 60 mg (NDC 65162-027-09) Unavailable Shortage of an active ingredient Shortage of an active ingredient
Capsule, 70 mg (NDC 65162-028-09) Unavailable Shortage of an active ingredient Shortage of an active ingredient

Apotex Corp. (Revised 09/17/2024)

Company Contact Information:
800-706-5575

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Capsule, 10 mg (NDC 60505-4739-1) Limited Availability Next resupply expected Oct 2024; limited inventory Shortage of an active ingredient
Capsule, 20 mg (NDC 60505-4740-1) Limited Availability Next resupply expected Oct 2024; limited inventory Shortage of an active ingredient
Capsule, 30 mg (NDC 60505-4741-1) Limited Availability Next resupply expected Oct 2024; limited inventory Shortage of an active ingredient
Capsule, 40 mg (NDC 60505-4742-1) Limited Availability Next resupply expected Oct 2024; limited inventory Shortage of an active ingredient
Capsule, 50 mg (NDC 60505-4743-1) Limited Availability Next resupply expected TBD; limited inventory Shortage of an active ingredient
Capsule, 60 mg (NDC 60505-4744-1) Limited Availability Next resupply expected TBD; limited inventory Shortage of an active ingredient
Capsule, 70 mg (NDC 60505-4745-1) Limited Availability Next resupply expected TBD; limited inventory Shortage of an active ingredient

Hikma Pharmaceuticals USA, Inc. (Reverified 11/25/2024)

Company Contact Information:
800-631-2174

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Capsule, 20 mg (NDC 0054-0370-25) Limited Availability Available on allocation Shortage of an active ingredient
Capsule, 30 mg (NDC 0054-0371-25) Limited Availability Available on allocation Shortage of an active ingredient
Capsule, 40 mg (NDC 0054-0372-25) Limited Availability Available on allocation Shortage of an active ingredient
Capsule, 50 mg (NDC 0054-0373-25) Limited Availability Available on allocation Shortage of an active ingredient
Capsule, 60 mg (NDC 0054-0374-25) Limited Availability Available on allocation Shortage of an active ingredient
Capsule, 70 mg (NDC 0054-0375-25) Limited Availability Available on allocation Shortage of an active ingredient

Lannett Company, Inc. (Reverified 12/02/2024)

Company Contact Information:
844-834-0530

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Capsule, 10 mg (NDC 0527-4661-37) Unavailable Shortage of an active ingredient
Capsule, 20 mg (NDC 0527-4662-37) Limited Availability Shortage of an active ingredient
Capsule, 30 mg (NDC 0527-4663-37) Limited Availability Shortage of an active ingredient
Capsule, 40 mg (NDC 0527-4664-37) Limited Availability Shortage of an active ingredient
Capsule, 50 mg (NDC 0527-4665-37) Limited Availability Shortage of an active ingredient
Capsule, 60 mg (NDC 0527-4666-37) Limited Availability Shortage of an active ingredient
Capsule, 70 mg (NDC 0527-4667-37) Unavailable Shortage of an active ingredient

Mylan Pharmaceuticals Inc., a Viatris Company (Reverified 12/03/2024)

Company Contact Information:
800-796-9526

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Capsule, 10 mg (NDC 0378-6854-77) Limited Availability Allocating limited inventory Shortage of an active ingredient
Capsule, 20 mg (NDC 0378-6855-77) Limited Availability Allocating limited inventory Shortage of an active ingredient
Capsule, 30 mg (NDC 0378-6856-77) Limited Availability Allocating limited inventory Shortage of an active ingredient
Capsule, 40 mg (NDC 0378-6857-77) Limited Availability Allocating limited inventory Shortage of an active ingredient
Capsule, 50 mg (NDC 0378-6858-77) Limited Availability Allocating limited inventory Shortage of an active ingredient
Capsule, 60 mg (NDC 0378-6859-77) Limited Availability Allocating limited inventory Shortage of an active ingredient
Capsule, 70 mg (NDC 0378-6860-77) Limited Availability Allocating limited inventory Shortage of an active ingredient

Rhodes Pharmaceuticals L.P. (Reverified 12/02/2024)

Company Contact Information:
888-827-0616

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Capsule, 10 mg (NDC 42858-161-01) Available
Capsule, 20 mg (NDC 42858-162-01) Available
Capsule, 30 mg (NDC 42858-163-01) Unavailable Resupply by late November 2024 Shortage of an active ingredient
Capsule, 40 mg (NDC 42858-164-01) Unavailable Resupply by late November 2024 Shortage of an active ingredient
Capsule, 60 mg (NDC 42858-166-01) Available
Capsule, 50 mg (NDC 42858-165-01) Unavailable Resupply by late November 2024 Shortage of an active ingredient
Capsule, 70 mg (NDC 42858-167-01) Unavailable Resupply by late December 2024 Shortage of an active ingredient

Solco Healthcare US, LLC (Reverified 09/03/2024)

Company Contact Information:
866-931-9829

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Capsule, 10 mg (NDC 43547-602-10) Limited Availability On allocation Shortage of an active ingredient
Capsule, 20 mg (NDC 43547-603-10) Limited Availability On allocation Shortage of an active ingredient
Capsule, 30 mg (NDC 43547-604-10) Limited Availability On allocation Shortage of an active ingredient
Capsule, 40 mg (NDC 43547-605-10) Limited Availability On allocation Shortage of an active ingredient
Capsule, 50 mg (NDC 43547-606-10) Limited Availability On allocation Shortage of an active ingredient
Capsule, 60 mg (NDC 43547-607-10) Limited Availability On allocation Shortage of an active ingredient
Capsule, 70 mg (NDC 43547-608-10) Limited Availability On allocation Shortage of an active ingredient

SpecGx LLC (Revised 12/02/2024)

Company Contact Information:
800-325-8888

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Capsule, 10 mg (NDC 0406-5111-01) Limited Availability Allocations to all customers. Shortage of an active ingredient
Capsule, 20 mg (NDC 0406-5112-01) Limited Availability Allocations to primary customers only. Backorder expected in Dec. Next release in Feb for short term recovery. Shortage of an active ingredient
Capsule, 30 mg (NDC 0406-5113-01) Unavailable Backorder with next release projected in February for short term recovery. Shortage of an active ingredient
Capsule, 40 mg (NDC 0406-5114-01) Unavailable Backorder. Next release early Jan. Shortage of an active ingredient
Capsule, 50 mg (NDC 0406-5115-01) Unavailable Backorder. Next release early January. Backorder expected again in February Shortage of an active ingredient
Capsule, 60 mg (NDC 0406-5116-01) Unavailable Backorder. Next release early Jan. Backorder expected again in Jan. Shortage of an active ingredient
Capsule, 70 mg (NDC 0406-5117-01) Unavailable Backordered Shortage of an active ingredient

Sun Pharmaceutical Industries, Inc. (Reverified 10/23/2024)

Company Contact Information:
800-818-4555

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Capsule, 10 mg (NDC 57664-046-88) Limited Availability Shortage of an active ingredient
Capsule, 30 mg (NDC 57664-048-88) Limited Availability Shortage of an active ingredient
Capsule, 30 mg (NDC 57664-048-88) Limited Availability Shortage of an active ingredient
Capsule, 40 mg (NDC 57664-049-88) Limited Availability Shortage of an active ingredient
Capsule, 50 mg (NDC 57664-050-88) Limited Availability Shortage of an active ingredient
Capsule, 60 mg (NDC 57664-051-88) Limited Availability Shortage of an active ingredient
Capsule, 70 mg (NDC 57664-052-88) Limited Availability Shortage of an active ingredient

Takeda Pharmaceuticals USA Inc. (Reverified 11/18/2024)

Company Contact Information:
877-TAKEDA-7 (1-877-825-3327)

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Vyvanse, Capsule, 10 mg (NDC 59417-101-10) Available
Vyvanse, Capsule, 20 mg (NDC 59417-102-10) Available
Vyvanse, Capsule, 30 mg (NDC 59417-103-10) Available
Vyvanse, Capsule, 40 mg (NDC 59417-104-10) Available
Vyvanse, Capsule, 50 mg (NDC 59417-105-10) Available
Vyvanse, Capsule, 60 mg (NDC 59417-106-10) Available
Vyvanse, Capsule, 70 mg (NDC 59417-107-10) Available
Back to Top